News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
253–288
Matches
872
Sources here
21
Companies here
23
Search results Stored financial headlines

Active search

872 matching headlines

Ticker or company: IAGMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Quest Diagnostics Inc (DGX) Stock News Today

This article from TradingKey provides a news page for Quest Diagnostics Inc (DGX) stock. It includes current stock performance metrics like price, market cap, and P/E ratio. The page indicates that more news will be coming soon regarding DGX stock.

DGX main company
Sharemaestro market context Trend signal active 52 weeks +31.8% · Next-week setup positive 58.1% DGX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Qiagen N.V. Stock 12‑Month Price Target Raised to $44.52, Implies 7% Upside

Qiagen N.V.'s average price target has been increased from $43.87 to $44.52 by 17 analysts, suggesting a 7% potential upside based on its closing price. The consensus rating remains a "Buy" from 22 covering analysts. Investors can explore more price target data and analyst …

QGEN main company
Sharemaestro market context Price above Trend Line 52 weeks -14.1% QGEN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Iamgold Corp (IAG) (Q2 2026) Earnings Call Highlights: Record Cash Flow and Strategic Expansion ...

This article first appeared on GuruFocus. Release Date: August 07, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Iamgold Corp (NYSE:IAG) produced 188,100 ounces of gold in Q2 2026, bringing year-to-date production to …

IAG main company IAG main company IAG main company IAG main company
Sharemaestro market context Trend signal active 52 weeks +16.9% · Next-week setup positive 61.5% IAG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Qiagen NV | 6-K: Report of foreign private issuer (related to financial reporting)

This article is a 6-K filing by Qiagen NV, which is a report for a foreign private issuer. These reports are typically related to financial reporting and other significant company updates that are required by regulatory bodies.

QGEN main company
Sharemaestro market context Price above Trend Line 52 weeks -14.1% QGEN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Quantinno Capital Management LP Has $5.30 Million Stock Holdings in Qiagen N.V. $QGEN

Quantinno Capital Management LP significantly reduced its stake in Qiagen N.V. by 40.6% in the first quarter, now holding 132,392 shares valued at approximately $5.3 million. Despite this, Qiagen's recent quarterly earnings exceeded expectations, with EPS of $0.62 and revenue of $535 million, and …

QGEN main company
Sharemaestro market context Price above Trend Line 52 weeks -14.1% QGEN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

PTA-CMS: QIAGEN N.V.: Release of a capital market information

QIAGEN N.V. has filed its Form 6-K Report of Foreign Private Issuer for the quarterly period ended June 30, 2026, with the United States Securities and Exchange Commission (SEC). The document is now accessible on QIAGEN's website. This release provides important capital market information …

QGEN main company
Sharemaestro market context Price above Trend Line 52 weeks -14.1% QGEN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

QIAGEN N.V. (NYSE: QGEN) tops Q2 EPS outlook and reaffirms 2026 targets

QIAGEN N.V. exceeded its Q2 2026 EPS outlook with adjusted diluted EPS of $0.62, against an outlook of at least $0.60 CER, and reaffirmed its full-year 2026 guidance for net sales growth of about 1-2% CER and adjusted diluted EPS of at least $2.43 …

QGEN main company
Sharemaestro market context Price above Trend Line 52 weeks -14.1% QGEN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Insight Molecular Diagnostics Inc. (7OC0.MU) Analyst Insights, Price Targets & Recommendations

This article provides analyst insights, price targets, and recommendations for Insight Molecular Diagnostics Inc. (7OC0.MU). It lists several instances where analysts from Lake Street and Needham have maintained a "Buy" rating for the company's stock between February 2026 and April 2025. The current stock …

IMDX main company
Sharemaestro market context Price below Trend Line 52 weeks +66.8% IMDX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

QIAGEN N.V. (NYSE: QGEN) sets $0.35 dividend and $200M buyback cap

QIAGEN N.V. (NYSE: QGEN) announced it will convene its 2026 Annual General Meeting on June 24, 2026. Shareholders will vote on a proposed cash dividend of $0.35 per ordinary share, totaling approximately $72 million, payable July 14, 2026. Additionally, the agenda includes authorizing a …

QGEN main company QGE4 main company
Sharemaestro market context Price above Trend Line 52 weeks -14.1% QGEN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Lucid Diagnostics Inc (LUCD) Stock News Today

This page provides an overview of Lucid Diagnostics Inc (LUCD) stock news, including current trading information and a note that more news is coming soon. The stock is currently trading at 0.953 USD, down 0.05%, with a market cap of 124.88M. The article is …

LUCD main company
Sharemaestro market context Price below Trend Line 52 weeks -12.0% LUCD stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Carriage Services (CSV) Stock Sinks As Debt Fears Eclipse Steady Margins

Carriage Services (CSV) stock recently dropped significantly, largely due to investor concerns over the company's debt levels, specifically its 4.0x bank leverage. This fear overshadowed an otherwise steady Q2 2026 earnings report, which showed slight increases in revenue and net income, improved adjusted EBITDA …

CSV main company
Sharemaestro market context Price below Trend Line 52 weeks -19.5% CSV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Carriage Services, Inc. Stock 12‑Month Price Target Cut to $58, Implies 40% Upside

The average 12-month price target for Carriage Services, Inc. (CSV) stock has been reduced from $60 to $58 by five analysts, with forecasts ranging from $50 to $65 per share. This new target suggests a potential upside of approximately 40% from its August 5 …

CSV main company
Sharemaestro market context Price below Trend Line 52 weeks -19.5% CSV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

A Quick Look at Today's Ratings for Qiagen NV(QGEN.US), With a Forecast Between $45.5 to $46.09

This article provides a quick look at today's analyst ratings for Qiagen NV (QGEN.US), forecasting a target price between $45.50 and $46.09. It highlights the general sentiment and price targets from various financial institutions.

QGEN main company
Sharemaestro market context Price above Trend Line 52 weeks -14.1% QGEN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Carriage Services Inc (CSV) (Q2 2026) Earnings Call Highlights: Strategic Pricing Power Offsets Volume Decline, July Signals Recovery

Carriage Services Inc (CSV) reported a 3.1% increase in adjusted consolidated EBITDA in Q2 2026, reaching $33.3 million, despite a 3.5% decline in comparable funeral volume, primarily due to strong pricing power and cost discipline. The company's financial revenue grew 14% year-over-year, and management …

CSV main company
Sharemaestro market context Price below Trend Line 52 weeks -19.5% CSV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Diageo climbs Friday, outperforms market

Diageo PLC (DGE) shares increased by 3.32% to £17.90 on Friday, outperforming the FTSE 100 Index. The rise occurred on an overall positive trading day for the stock market, with the FTSE 100 gaining 0.31%. Despite the Friday climb, Diageo PLC closed 16.43% below …

DEO main company
Sharemaestro market context Price above Trend Line 52 weeks -14.3% DEO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

iA Financial Group Announces the Issuance of a Redemption Notice to Holders of 3.072% Subordinated Debentures due September 24, 2031

Not for distribution to U.S. newswire services or for dissemination in the United States. QUEBEC CITY, August 07, 2026--(BUSINESS WIRE)--Further to the approval of the Autorité des marchés financiers (Québec), iA Financial Corporation Inc. (the "Company") announces that it has sent today to all …

IAG main company
Sharemaestro market context Trend signal active 52 weeks +39.4% · Next-week setup positive 60.7% IAG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Quest Diagnostics Incorporated $DGX Holdings Trimmed by Empowered Funds LLC

Empowered Funds LLC significantly reduced its stake in Quest Diagnostics (NYSE:DGX) by 61.5% in the first quarter, selling over 15,000 shares. Despite this, institutional investors still own a substantial 88.06% of the company's stock. Quest Diagnostics exceeded Q1 earnings and revenue expectations, and analysts …

DGX main company
Sharemaestro market context Trend signal active 52 weeks +31.8% · Next-week setup positive 58.1% DGX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Guinness owner Diageo targets $1B in cost savings

This story was originally published on Food Dive. To receive daily news and insights, subscribe to our free daily Food Dive newsletter. Dive Brief: Guinness owner Diageo unveiled a $1 billion savings plan during the next three years to turn around the business. The …

DEO main company DEOP34 main company DEO main company DGED main company GUI main company DGE main company
Sharemaestro market context Trend signal started 52 weeks -2.3% DEO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Co-Diagnostics' Test Filing Draws on 1,400 Patients

Co-Diagnostics (Nasdaq: CODX) has submitted a Dual FDA 510(k) premarket notification and a concurrent CLIA Waiver by Application for its Co-Dx PCR Flu A/B & RSV upper respiratory multiplex test. This test is designed for use on the Co-Dx PCR Pro instrument in decentralized …

CODX main company
Sharemaestro market context Price below Trend Line 52 weeks -85.4% · Next-week setup negative 40.9% CODX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Co-Diagnostics submits FDA 510(k) for respiratory test

Co-Diagnostics, Inc. has submitted a Dual 510(k) premarket notification and a concurrent CLIA Waiver by Application to the FDA for its Co-Dx PCR Flu A/B & RSV upper respiratory multiplex test. This submission aims to allow the test to be used in decentralized point-of-care …

CODX main company
Sharemaestro market context Price below Trend Line 52 weeks -85.4% · Next-week setup negative 40.9% CODX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168

Niagen Bioscience has partnered with Evotec to advance the preclinical development of NB4168, their lead investigational candidate for rare pediatric diseases, particularly Ataxia Telangiectasia (A-T). Evotec will conduct pharmacokinetic, pharmacodynamic, and bioanalytical studies at their Verona campus, utilizing their INDiGO platform to accelerate the …

NAGE main company
Sharemaestro market context Price below Trend Line 52 weeks -69.7% · Next-week setup negative 43.5% NAGE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context